BIOMAT Database Logo BIOMAT Database Logo

Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide. 2010

Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Department of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.

Transgenic rats carrying human c-Ha-ras proto-oncogene (Hras128 rats) have been shown to be highly susceptible to induction of tumors. We have found an early induction of tongue tumors in Hras128 rats treated with 4-nitroquinoline 1-oxide (4NQO). 4NQO was administered to the Hras128 and wild-type Sprague-Dawley (SD) rats for 4 and 8 weeks, respectively. The experiment was terminated at 14 (Hras128 rats) and 28 (SD rats) weeks. Either during or after treatment with 4NQO, dysplastic hyperplasia, papilloma and squamous cell carcinoma were found on the tongue of both Hras128 and wild-type rats, with a higher incidence and multiplicity in Hras128 rats. Treatment of the Hras128 rats with 4NQO significantly increased cell proliferation in the tumor compared to the control rats. In the tongue tumors of the Hras128 rats, there was a significant increase in the mRNA expression levels of cyclin D1 and COX2. To examine whether this experimental system is useful for screening of the candidate agents for cancer preventive effect, nimesulide, a selective COX2 inhibitor, was tested in the present model. Nimesulide significantly decreased total multiplicity of tongue lesions compared to the control rats. Treatment of Hras128 rats with nimesulide caused a significant decrease in the levels of mRNA expression of cyclin D1 and COX2 in the tumor. Therefore, the current 4NQO-induced Hras128 rat tongue carcinogenesis model provides a simple and rapid system for investigating carcinogenesis process and evaluating the effect of possible cancer preventive agents for human tongue cancer.

UI MeSH Term Description Entries
D008297 Male Males
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014062 Tongue Neoplasms Tumors or cancer of the TONGUE. Cancer of Tongue,Tongue Cancer,Cancer of the Tongue,Neoplasms, Tongue,Cancer, Tongue,Cancers, Tongue,Neoplasm, Tongue,Tongue Cancers,Tongue Neoplasm
D015112 4-Nitroquinoline-1-oxide A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage. 4-Nitroquinoline-N-oxide,4 Nitroquinoline 1 oxide,4 Nitroquinoline N oxide

Related Publications

Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats.
April 2005, Cancer letters,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
May 2002, Carcinogenesis,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Prevention of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis by garlic.
June 2001, Fitoterapia,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Alterations of the nucleolar organizer regions during 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats.
February 1991, Carcinogenesis,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
January 2000, Japanese journal of cancer research : Gann,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
p16(CDKN2A) expression during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.
July 2009, Oral oncology,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
[Microangioarchitecture of 4-nitroquinoline 1-oxide (4NQO)-induced tongue carcinoma in rats].
August 1983, Shika gakuho. Dental science reports,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat.
April 1998, Cancer research,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Molecular basis of 4-nitroquinoline 1-oxide carcinogenesis.
August 1989, Japanese journal of cancer research : Gann,
Kuniko Naoi, and Nao Sunagawa, and Ichiro Yoshida, and Takamitsu Morioka, and Makoto Nakashima, and Masashi Ishihara, and Katsumi Fukamachi, and Yoshinori Itoh, and Hiroyuki Tsuda, and Naoki Yoshimi, and Masumi Suzui
Possible enhancing activity of diacylglycerol on 4-nitroquinoline 1-oxide induced carcinogenesis of the tongue in human c-Ha-ras proto-oncogene transgenic rats.
June 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Copied contents to your clipboard!